Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

1.13.11.20: cysteine dioxygenase

This is an abbreviated version!
For detailed information about cysteine dioxygenase, go to the full flat file.

Word Map on EC 1.13.11.20

Reaction

L-cysteine
+
O2
=
3-sulfinoalanine

Synonyms

3-mercaptopropionate dioxygenase, 3MDO, ADO, Arg-type CDO, BsCDO, CDO, CDO1, CDO2, CdoA, CdoB, cysteine dioxygenase, cysteine dioxygenase type 1, cysteine oxidase, Fe(II) cysteine dioxygenase, H16_A1614, H16_B1863, NP_251292, oxygenase, cysteine di-, PA2602, PCO1, PCO4

ECTree

     1 Oxidoreductases
         1.13 Acting on single donors with incorporation of molecular oxygen (oxygenases)
             1.13.11 With incorporation of two atoms of oxygen
                1.13.11.20 cysteine dioxygenase

Disease

Disease on EC 1.13.11.20 - cysteine dioxygenase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenocarcinoma
The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.
Adenocarcinoma of Lung
Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
Autoimmune Diseases
An insight into the mechanism of human cysteine dioxygenase. Key roles of the thioether-bonded tyrosine-cysteine cofactor.
Barrett Esophagus
The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.
Breast Neoplasms
Differential Prognostic Relevance of Promoter DNA Methylation of CDO1 and HOPX in Primary Breast Cancer.
Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines.
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.
Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome.
Carcinogenesis
Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma.
Carcinoma
Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma.
Carcinoma, Hepatocellular
Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma.
Carcinoma, Non-Small-Cell Lung
Correction: Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer.
Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer.
Promoter hypermethylation of cysteine dioxygenase type 1 in patients with non-small cell lung cancer.
Colorectal Neoplasms
Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.
Detection of methylated CDO1 in plasma of colorectal cancer; a PCR study.
cysteine dioxygenase deficiency
Cysteine-S-sulfate: brain damaging metabolite in sulfite oxidase deficiency.
Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus.
Digestive System Neoplasms
The role of ferroptosis in digestive system cancer.
Esophageal Squamous Cell Carcinoma
Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma.
Gallbladder Diseases
Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
Gallbladder Neoplasms
Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
Hepatoblastoma
Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells.
Intellectual Disability
Cysteine-S-sulfate: brain damaging metabolite in sulfite oxidase deficiency.
Leukemia
Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support.
Liposarcoma
Differential expression of cysteine dioxygenase 1 in complex karyotype liposarcomas.
Lung Neoplasms
Correction: Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer.
Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer.
Promoter hypermethylation of cysteine dioxygenase type 1 in patients with non-small cell lung cancer.
Neoplasms
Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.
Differential expression of cysteine dioxygenase 1 in complex karyotype liposarcomas.
Differential Prognostic Relevance of Promoter DNA Methylation of CDO1 and HOPX in Primary Breast Cancer.
Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma.
Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
Involvement of the Cys-Tyr cofactor on iron binding in the active site of human cysteine dioxygenase.
Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma.
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.
Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN).
The role of ferroptosis in digestive system cancer.
Pancreatic Neoplasms
Analysis of the methylation of CpG islands in the CDO1, TAC1 and CHFR genes in pancreatic ductal cancer.
Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
Pantothenate Kinase-Associated Neurodegeneration
Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus.
Retinoblastoma
The role of ferroptosis in digestive system cancer.
Stomach Neoplasms
Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer.
Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells.
Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.